In response to anemia, erythropoietin (Epo) gene transcription is markedly induced in the kidney and liver. To elucidate how Epo gene expression is regulated in vivo, we established transgenic mouse lines expressing green fluorescent protein (GFP) under the control of a 180-kb mouse Epo gene locus. GFP expression was induced by anemia or hypoxia specifically in peritubular interstitial cells of the kidney and hepatocytes surrounding the central vein.
Introduction
In order to maintain proper homeostasis during growth and development, the regulation of gene expression needs to be strictly controlled, especially at the transcriptional level. For instance, in response to anemia and hypoxia, erythropoietin (Epo) gene transcription is activated in the kidney and liver (reviewed in Ebert and Bunn 1 ). Epo is then secreted from these tissues to stimulate erythropoiesis in hematopoietic tissues. The kidney produces approximately 90% of the total Epo during the response to anemia, 2 indicating that Epo gene expression is under strict tissue-specific regulation. Thus, the Epo gene provides an intriguing model for understanding gene expression in higher eukaryotes. Furthermore, dysfunctional Epo gene regulation has been
shown to underlie the pathogenesis of renal anemia. 3, 4 As such, recombinant Epo has been used widely as a powerful drug for treating patients with anemia (reviewed in Jelkmann 5 ).
Epo gene expression in response to anemia and/or hypoxia has been vigorously analyzed by exploiting the human hepatoma cell lines Hep3B and HepG2 that produce Epo in a hypoxia-inducible manner. 6 An important finding from these studies was that Epo gene expression is regulated by an enhancer located 3´ to the transcriptional termination site. 7 This 3´ enhancer contains a hypoxia response element (HRE) that has been shown to bind hypoxia inducible transcription factors (HIFs). 7 A binding sequence for nuclear receptor also resides in the enhancer. 1, 8 Thus, these two cis-acting elements may control Epo gene expression in a hypoxia-inducible manner (reviewed in Koury 9 ).
A GATA factor-binding motif (GATA box) has been identified in the core promoter region of the Epo gene, where a TATA box normally resides. 10 We have found that this GATA box actively participates in Epo gene regulation. The GATA box acts as a negative regulatory element in the hepatoma cell lines. 10 During normoxic conditions, GATA transcription factors bind to the For personal use only. on August 16, 2017 . by guest www.bloodjournal.org From GATA box and repress Epo gene transcription, but when exposed to hypoxia, GATA binding markedly decreases, with a marked increase in Epo gene expression. 10, 11 Although the mechanisms underlying inducible gene expression of the Epo gene are generally understood, the basis of tissue-specific Epo gene regulation is largely unknown.
Constitutive expression, as well as ectopic transgene expression, has been frequently detected in several transgenic mouse reporter studies utilizing constructs containing less than 20-kb of the Epo gene flanking region. [12] [13] [14] [15] In agreement, our own transgenic reporter gene expression analysis demonstrated that an 11-kb mouse Epo gene fragment, which incorporates the two important regulatory elements mentioned above (the promoter GATA motif and 3´ enhancer), was unable to fully recapitulate Epo gene expression (N.S and M.Y., unpublished data, March 25, 2002 ). We therefore realized that regulatory element(s) critical for Epo gene expression must be contained in further upstream or downstream regions surrounding the Epo locus.
An unsolved, but important issue in Epo gene regulation is the identification of precisely which kidney cells actively produce Epo. This topic is controversial; some reports claim that proximal tubular cells produce Epo, 14, 16 whereas others present evidence that the Epo producing cell population might be glomerular, 17 mesangial, 18 or interstitial cells of the renal cortex. 13, [19] [20] [21] [22] [23] We surmise that these discrepancies are most likely due to a low sensitivity in the detection of Epo.
To elucidate in this study how inducible and tissue-specific transcription of the Epo gene is attained, we established bacterial artificial chromosome (BAC) transgenic mouse lines expressing green fluorescent protein (GFP) as a reporter under the control of a 180-kb mouse Epo gene locus. 24 This 180-kb region can sufficiently recapitulate inducible transgene expression in a tissue-specific manner, including expression in the kidney and liver. The GFP labeling clearly identified the renal Epo-producing (REP) population as interstitial cells.
For personal use only. on August 16, 2017 . by guest www.bloodjournal.org From Surprisingly, we discovered that REP cells have a neuron-like shape and express marker antigens found in neuronal cells. Furthermore, we also found that a single nucleotide mutation in the promoter GATA box can cause constitutive ectopic expression of GFP in the renal distal tubules, collecting ducts, and certain epithelial cells of other tissues. Thus, GATA box-based repression is essential for inducible and cell-type specific Epo gene expression.
Materials and methods

Bacterial artificial chromosome (BAC) transgenes
A BAC clone (Epo-60K/BAC, RP27826) containing the Epo gene and flanking regions was obtained from a C57black/6 mouse genomic library (Incyte Genomics). To make the wt-Epo-GFP construct, GFP cDNA was integrated into Epo-60K/BAC in E. coli EL250 as described previously. 25, 26 For construction of the mutant Epo-GFP transgenes (m1-Epo-GFP and m2-Epo-GFP), the PCR-based mutant 5´ arms of the targeting vectors were used.
11,27
Recombinant BAC clones were identified through sequencing, restriction enzyme analysis and Southern blotting. BAC transgenic constructs were purified from a bacterial cell suspension cultured in LB/chloramphenicol (25 µg/mL) for 24 h at 32°C using a Nucleobond BAC DNA preparation kit (Macherey-Nagel, Düren, Germany). The purified DNA was linearized by digestion with λ-terminase (Epicentre technologies) and purified by pulse-field gel electrophoresis.
28
Mice
Purified linear transgenes (5 ng/µL) were microinjected into the pronuclei of fertilized eggs from BDF1 parents. Transgenic mice were screened by PCR genotyping of tail DNA using the following three pairs of primers. BAC1F (5´-GTGCGGGCCTCTTCGCTATT-3´) with BAC1R
For personal use only. on August 16, 2017 . by guest www.bloodjournal.org From (5´-CAGGTCGACTCTAGAGGATC-3´) and BAC2F (5´-AGTGTCACCTAAATAGCTTG-3´) with BAC2AR (5´-CAGTACTGCGATGAGTGGCA-3´) were used to amplify the BAC vector sequences at the 3´and 5´ inserts, respectively. The primer set GFPs4 (5´-CTGAAGTTCATCTGCACCACC-3´) and GFPas4 (5´-GAAGTTGTACTCCAGCTTGTGC-3´) was used to amplify the GFP cDNA. 29 Southern blotting analyses were carried out to determine the transgene copy numbers. Genomic tail DNA was prepared and digested with ApaI. Southern membranes were hybridized with a 32 P-labeled probe. The copy numbers of the transgenes were determined by the intensities of the bands. To induce profound anemia (Hct < 15%), six-to eight-week-old mice were bled from the retro-orbital plexus (0. 
Immunostaining
Tissues were fixed in 4% paraformaldehyde for 30 min and embedded in OCT compound (Sakura-Finetechnical, Tokyo). Sections 10 µm in thickness were incubated with rabbit anti-GFP polyclonal antibody (diluted 1:1000; Molecular Probes) or anti-GATA-4 antibody (diluted 1:500; Santa Cruz) at 4˚C overnight. After treatment with hydrogen peroxide, sections were incubated with horseradish peroxidase-conjugated anti-rabbit IgG secondary antibody.
Color detection was performed using diaminobenzidine as a chromogen (brown staining).
Hematoxylin was used as a counter stain. To detect the expressions of CD31 and Mac1, frozen 
RT-PCR
Liver sections were micro-dissected with the Leica laser micro-dissection system (LMD, Leica) and RNAs were purified using RNeasy (Qiagen). Total RNAs were purified using ISOGEN (Nippon-Gene, Tokyo). Reverse-transcription was performed with SenscriptRT (Qiagen). Epo mRNA levels were measured quantitatively using the ABI PRISM 7700 (Perkin-Elmer) and the primer pair 5´-GAGGCAGAAAATGTCACGATG-3´ and 5´-CTTCCACCTCCATTCTTTTCC-3´ with FAM-labeled oligo-DNA probe (5´-TGCAGAAGGTCCCAGACTGAGTGAAAATA-3´). 32 Glyceraldehyde phosphate dehydrogenase (GAPDH) was used as an internal standard. 29 Semi-quantitative RT-PCR analysis of Epo-GFP transgene expression was performed using the primer pair 5´-AAGGATGAAGACTTGCAGCG-3´ and 5´-GAAGTTGTACTCCAGCTTGTGC-3´.
Hypoxanthine guanine phosphoribosyl transferase (HPRT) was used as an internal control using 5´-GCTGGTGAAAAGGACCTCT-3´ and 5´-CACAGGACTAGAACACCTGC-3´ primers.
29
Chromatin immunoprecipitation (ChIP)
Normal renal medulla (10 mg) was minced by needling and fixed with 1% formaldehyde for 10
For personal use only. on August 16, 2017 . by guest www.bloodjournal.org From min. Sample in a 200 µL aliquot was sonicated for 10 sec on ice 12 times by a 2-mm microtip sonicator (Branson, Danbury, CT). One half of the sonicated sample was used as pre-immunoprecipitated control (Input), while the other half was incubated with antibody against GATA-2, GATA-3 or normal rabbit IgG (Santa Cruz). Antibody-bound chromatin complexes were precipitated with an Immunoprecipitation Kit (Upstate Biotechnology). To detect the promoter region in the precipitated chromatin complexes, PCR was performed using the following primers: 5´-TCACGCACACACAGCTTCAC-3´ and 5´-CACGCTGCAAGTCTTCATCC-3´ for the Epo promoter; 5´-TTATCTGGAGTCCATTAATGAGG-3´ and 5´-CTGCTCGGCCTTCTGAGCGCTG-3´ for the Aquaporin-2 (Aqp2) gene promoter; 5´-TATGGCGGGCAAGAAGTTGA-3´ and 5´-GTACTAGGCCAGGACTAGTG-3´ for the Gata1 gene promoter. 33 The Aqp2 and Gata1 promoters were used as positive and negative controls, respectively.
Results
Regulatory region for tissue-specific and inducible Epo gene expression
To obtain a genomic DNA fragment suitable for our in vivo reporter expression analysis, we screened several BAC clones containing the mouse Epo gene and finally selected a 180-kb BAC clone (Epo-60K/BAC) ( Figure 1A ). The region spanning exon II to intron IV of the Epo gene in the BAC clone was replaced with a GFP reporter gene through standard homologous recombination. [24] [25] [26] The GFP gene was inserted in frame in such a manner that GFP expression would mimic Epo gene expression ( Figure 1A ). We confirmed the authenticity of the recombinant BAC clone by Southern blotting and DNA sequencing (data not shown). 24 The BAC-derived transgene (wt-Epo-GFP) was microinjected into fertilized eggs and three transgenic mouse lines were established. Transgene expression could not be detected under While the expression of GFP from the transgenic BAC clones was far more stable than that from the plasmid transgenes in mouse in vivo, we also noticed a variation in the intensity of fluorescence between the lines. The green fluorescence intensities (data not shown) were not related to the transgene copy numbers ( Figure 1C ). This data suggests that the BAC transgene might be affected to some extent by the integration position effect. We confirmed integration of the intact BAC transgene for all the lines of transgenic mice by a series of PCR and Southern blotting analyses (data not shown).
Renal Epo-producing cells are peritubular interstitial cells expressing neuronal markers
An important prerequisite for the current study was to elucidate the mechanisms regulating Epo gene expression by identifying the precise cells in the kidney that produce Epo, since earlier conclusions were controversial. 24 To this end, we exploited normal wt-Epo-GFP (Figure 2A) and wild-type mice ( Figure 2C ) and wt-Epo-GFP mice bled to induce anemia ( 
Epo-GFP expression in hepatocytes
Under severe anemic conditions, Epo production also occurs in the liver, so we examined GFP expression in hepatocytes. Bleeding anemia gave rise to the emergence of GFP-positive hepatocytes, which rapidly increased in number as the Hct score fell ( 
A mutation in the GATA box results in constitutive GFP expression in epithelial cells
Our previous analyses showed that in Hep3B and HepG2 cells, GATA-2 represses Epo gene expression by binding to its GATA box located 30-bp 5´ to the transcription start site. 10, 11 To ascertain whether this repression occurs in vivo, we examined GATA box activity using the Epo-GFP BAC transgenic reporter system. For this purpose, we mutated the GATA box in the wt-Epo-GFP construct to TATA ( Figure 5A m1-Epo-GFP), to which the GATA factors cannot bind. 11 As there was the possibility that TATA-binding factor (TBP) may recognize the -30
TATA box in the m1-Epo-GFP construct and activate Epo gene expression in place of the GATA factors, 10, 35 we prepared another mutant that is not recognizable by either GATA or TBP (TTTA mutant, m2-Epo-GFP transgene; Figure 5A ).
We established three transgenic mouse lines each for the m1-Epo-GFP (Lines 1A, 1B, and 1C) and m2-Epo-GFP (Lines 2A, 2B, and 2C) constructs ( Figure 1D ) and evaluated GFP expression under anemic conditions. To our surprise, GFP was highly expressed in the distal tubules and collecting ducts of the m1-Epo-GFP mutant transgenic mice, even in non-anemic conditions ( Figure 5B ,C,E,F). This ectopic expression was reproducible in all three lines of m1-Epo-GFP mutant transgenic mice (data not shown). GFP was also expressed in both normal and anemic conditions in the bile duct epithelia, bronchial epithelia and thymus epithelia of the m1-Epo-GFP mutant transgenic mice ( Figure 5H ,I,K,L; Table 1 
GATA-2 and GATA-3 in epithelial cells bind to the GATA box
Using Gata2-GFP knock-in and Gata3-LacZ knock-in mouse lines, 30, 31 we examined which GATA family members are expressed in the epithelial cells that constitutively expressed the Table 1 ). In kidney, both Gata2 and Gata3 were expressed in the distal tubules and collecting ducts, as seen by GFP immunostaining of Gata2-GFP knock-in mouse kidney ( Figure 6A,B) and LacZ staining of Gata3-LacZ knock-in mouse kidney ( Figure   6C ,D). Immunohistochemical staining with anti-GATA-4 antibody of wild-type mouse kidney showed that the distal tubules and collecting ducts were negative for GATA-4 expression. Both
Gata2-GFP and GATA-4 were detected in REP cells ( Figure 6B ,F arrows; Table 1 ).
The specific binding of these GATA factors to the GATA sequence in vivo was investigated by means of a chromatin immunoprecipitation (ChIP) assay, exploiting the samples from the normal renal medulla where most of the cells expressed the mutant Epo-GFP transgenes and Gata2 and Gata3 genes. We found that the promoter region of the Epo gene did indeed immunoprecipitate with anti-GATA-2 and anti-GATA-3 antibodies ( Figure 6G top panel) . The promoter region of the Aquaporin-2 (Aqp2) gene was also immunoprecipitated. The Aqp2 promoter served as a positive control, as it is known to be a target of the GATA factors in renal tubules ( Figure 6G middle panel) . 36 Binding of GATA-2 and GATA-3 to the Epo promoter seemed to be specific, since we did not detect the Gata1 gene promoter containing GATA sequence in the ChIP assay ( Figure 6G bottom panel) . 33 These results support our contention that GATA-2 and GATA-3 constitutively repress Epo gene expression in renal tubular cells through binding to the GATA element. As for the GATA factors in the other epithelial cell lineages that were positive for the mutant transgene expression, we suggest concomitant GATA factor expression (Table 1) . While GATA-6 expression is not examined in this study, it has been reported that GATA-6 is expressed in the bile duct and bronchial epithelium. [37] [38] [39] Although GATA-3 expression was not detected in the thymic epithelium in this study (Table 1) , expression and essential contribution of GATA-3 to the thymic epithelium has been found (T. 
Discussion
To address the mechanisms underlying the regulation of Epo gene expression in a tissue-specific manner and in response to anemia/hypoxia, we utilized a BAC-based GFP reporter transgenic mouse strategy and the coding region of the Epo gene was replaced with GFP. GFP expression in wt-Epo-GFP BAC transgenic mice recapitulated the inducible and tissue-specific expression of the Epo gene. Importantly, our analysis identified REP cells in the kidney as the Epo producing cells, which showed specific peritubular localization, a unique arboroid shape and neuronal marker expression. Furthermore, a novel regulatory mechanism of Epo gene regulation was discovered that utilized the GATA box.
RT-PCR analysis demonstrated that the wt-Epo-GFP transgene faithfully recapitulated endogenous Epo gene expression in mouse tissues under both normal and anemic/hypoxic conditions. Previous Epo transgenic mouse studies revealed that a 33-kb genomic fragment of the human Epo transgene gave rise to hypoxia-inducible expression of human Epo in the kidney and liver. 12, 13, 15 In most of the mouse lines, the transgene expression was accompanied by ectopic expression and also resulted in polycythemia, indicating that the transgene used did not contain the full regulatory region to stably control Epo gene expression with cell-type specific manner in vivo. On the contrary, the BAC-based wt-Epo-GFP transgene employed in our study not only reiterated the endogenous Epo gene expression, but avoided the ectopic expression of Epo observed in other tissues and cell types. We therefore concluded that the 180-kb genomic region in the BAC contained virtually all the necessary regulatory elements needed for Epo 13, [19] [20] [21] [22] [23] The stellar or arboroid shape of the REP cell expresses the neural cell marker genes, and forms clusters in the anemic kidney. These observations suggest that the reticular network of REP cells may contribute to the regulation of Epo-production by sensing a low oxygen tension.
A widely believed idea in need of validation is that Epo must be produced by specifically sensing the cellular oxygen tension. Epo-producing cells are localized in the most hypoxic regions of the kidney and liver, supporting their ability to rapidly sense hypoxia. 24 We found that the numbers of GFP-positive cells in the kidney and liver increased exponentially with escalating anemia, showing a counter-parallel relationship with the Hct. These data further implied that Epo production is controlled through the increase in the number of Epo-expressing cells rather than by the changes in the expression level of each Epo-producing cell. 34 In contrast, the expression level of Epo appeared to be much higher in REP cells than in hepatocytes on the basis of GFP fluorescence intensity. This suggested a differential expression level of Epo dependent on the cell type. Indeed, most Epo in the adult body is produced by the kidney, 2 even though the population of REP cells is minor compared to that of hepatocytes.
In this regard, it is interesting to note that Epo is also minimally expressed in several tissues besides kidney and liver. These Epo producing tissues include the brain, heart, and testis (reviewed in Suzuki et al 24 and Brines and Cerami 40 ). However, we could not detect GFP expression from the wt-Epo-GFP transgene in any of these tissues. One plausible explanation for this discrepancy is that the expression level of Epo in these tissues was below the level of detection. That the 180-kb genomic fragment lacks specific enhancers important for Epo gene 41 We previously reported that GATA factors repressed the production of Epo in cultured hepatoma cells under normoxic conditions through binding to the Epo gene promoter, and this repression decreased in response to hypoxic stress. 3, 10, 11 To examine whether this GATA regulation is actually operating in vivo in response to hypoxia, a transgenic mouse study was As for the molecular mechanism underlying the function of GATA factors, we suggest one possibility, as depicted in Figure 7 . In this scenario, we assume that there may be an enhancer in the vicinity of the Epo gene that is important for the expression of other genes in the epithelial cell lineage. GATA factors may act to insulate the regulatory influence of this presumptive epithelial enhancer by binding to the GATA box. In contrast, while we detected the expression of GATA-2 and GATA-4 in REP cells, these GATA factors did not appear to affect Epo gene expression through its promoter GATA box and GFP expression from the GATA mutant transgene was induced normally upon bleeding anemia. This observation indicates that the hypoxia-responsive enhancer can drive Epo gene expression regardless of GATA-based repression. In addition to the authentic Epo-producing cells (REP cells and hepatocytes; Figure 7A ) and epithelial cells ( Figure 7B ), there is a third cell lineage in terms of Epo gene regulation.
In these cells, Epo expression would be permanently silenced by epigenetic mechanisms that are independent of the GATA box and hypoxic threshold ( Figure 7C ).
GATA factors have been found to activate transcription, 42 but recently repressive gene regulation by GATA factors has also been discovered, including the observation that the PPARγ gene in preadipocytes is repressed by GATA-2 and GATA-3 in the immature stage, but that this repression is abrogated after cellular differentiation. 43 In contrast, this study demonstrated that
Epo gene expression in epithelial cells is constitutively repressed by GATA factors. This is a novel regulatory system exploiting the GATA box and this element shows extremely high conservation among mammalian Epo gene sequences. 44 We surmise that this novel mechanism may rely on the insulator-like functions of GATA factors. 45 Finally, it should be noted that tumors can derive from renal tubular epithelia and are occasionally accompanied by polycythemia. Many of these tumors constitutively produce Epo. 46, 47 Since a single nucleotide mutation in the GATA box of the Epo-GFP transgene caused constitutive transgene expression in renal tubular cells, this study suggests that there may be some defects in the GATA signaling pathway in the epithelial tumor cells that leads to ectopic Epo gene expression. This observation led us to speculate that we may be able to develop an alternative treatment for Epo-dependent anemia by controlling GATA factor function in epithelial cells.
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The GFP expression of wild-type (wt-Epo-GFP) and GATA mutant (m1-Epo-GFP and m2-Epo-GFP) transgenic mice was examined under normal (N) and anemic (A) conditions. 
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